Salvatore Brugaletta

Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

Ortega-Paz L, Brugaletta S, Gomez-Lara J, Alfonso F, Cequier A, Romaní S, Bordes P, Serra A, Iñiguez A, Salinas P, García del Blanco B, Goicolea J, Hernández-Antolín R, Cuesta J, Gómez-Hospital JA, Sabaté M

August 5, 2022 | 10.4244/EIJ-D-21-00651

EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology.

Van Belle E, Teles R, Pyxaras S, Kalpak O, Johnson T, Barbash I, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri Ferre J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio AS, Estévez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D

May 16, 2021 | 10.4244/EIJ-D-18-00448

Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion

Freixa X, Cepas-Guillen P, Flores-Umanzor E, Regueiro A, Sanchis L, Fernandez-Valledor A, Brugaletta S, Carretero M, Vidal B, Masotti M, Martin-Yuste V, Roqué M, Sitges M, Sabaté M

February 5, 2021 | 10.4244/EIJ-D-20-00886

Target lesion revascularisation of bioresorbable metal scaffolds: a case series study and literature review

Ortega-Paz L, Brugaletta S, Gomez-Lara J, Sanchis J, Fernández-Díaz J, Artaiz-Urdaci M, Alfonso F, Garcia-Garcia H, Sabaté M

January 20, 2021 | 10.4244/EIJ-D-19-00421

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romaní S, Serra A, Salinas P, García del Blanco B, Goicolea J, Hernández-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gómez-Hospital JA, Sabaté M

December 4, 2020 | 10.4244/EIJ-D-20-00198

PCR e-Course: reshaping education in exceptional circumstances

Brugaletta S, Capodanno D, Fajadet J, Wijns W

June 25, 2020 | 10.4244/EIJV16I3A30

Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial

Gomez-Lara J, Salvatella N, Romaguera R, Brugaletta S, Nato M, Roura G, Ferreiro J, Teruel L, Gracida M, Sabaté M, Vaquerizo B, Cequier A, Gomez-Hospital J

June 12, 2020 | 10.4244/EIJ-D-18-01203

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Munzel T, Cequier A, Buono A, Serruys P, Sabaté M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P

March 20, 2020 | 10.4244/EIJ-D-18-01080

Coronary artery lesion phenotype in frail older patients with non-ST-elevation acute coronary syndrome undergoing invasive care

Gu S, Mintz G, Calvert P, Ford G, Neely D, Brugaletta S, Veerasamy M, Sinclair H, Batty J, Qiu W, Kunadian V

June 12, 2019 | 10.4244/EIJ-D-18-00848

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial

Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M

June 12, 2019 | 10.4244/EIJ-D-18-00247

Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study

Hioki H, Brugaletta S, Ishida K, Campo G, Biscaglia S, Ortega-Paz L, Cortese B, Varricchio A, Latib A, Sabaté M, Tespili M, Ielasi A

May 20, 2019 | 10.4244/EIJ-D-18-00504

Device specificity of vascular healing following implantation of bioresorbable vascular scaffolds and bioabsorbable polymer metallic drug-eluting stents in human coronary arteries: the ESTROFA OCT BVS vs. BP-DES study

de la Torre Hernandez J, Gonzalo N, Otaegui I, Rumoroso J-R, Gutierrez H, Alfonso F, Martí G, Frutos AS, Brugaletta S, Menchero A, Garcia Camarero T, Biagioni C, Escaned J

December 20, 2018 | 10.4244/EIJ-D-17-00952

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P

December 7, 2018 | 10.4244/EIJ-D-18-00839

Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial

Sotomi Y, Onuma Y, Liu S, Asano T, Eggermont J, Katagiri Y, Cavalcante R, de Winter RJ, Wykrzykowska JJ, Brugaletta S, Räber L, Sabaté M, Windecker S, Dijkstra J, Serruys P

August 24, 2018 | 10.4244/EIJ-D-17-00884

Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy

Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska JJ, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00461

Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up

Paoletti G, Gomez-Lara J, Brugaletta S, Nato M, Romaguera R, Roura G, Ferreiro JL, Teruel L, Gracida M, Ortega-Paz L, Gomez-Hospital J, Sabaté M, Cequier A

June 20, 2018 | 10.4244/EIJ-D-17-00255

First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial

von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska JJ, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys P, Sabaté M

April 20, 2018 | 10.4244/EIJ-D-17-00462

First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold

Kochman J, Kołtowski Ł, Tomaniak M, Jąkała J, Proniewska K, Legutko J, Roleder T, Pietrasik A, Rdzanek A, Kochman W, Brugaletta S, Opolski G, Regar E

April 6, 2018 | 10.4244/EIJ-D-17-00311

Moving fast towards the future: the role of #SoMe in learning cardiology

Brugaletta S

March 20, 2018 | 10.4244/EIJV13I16A305

Salvatore Brugaletta

Latest news